142 related articles for article (PubMed ID: 1756327)
1. Alpha-interferon broadens the difference between surviving fractions of normal and leukemic progenitor cells in vitro by heat: its application to marrow purging.
Moriyama Y; Goto T; Nikkuni K; Aoki A; Furukawa T; Narita M; Koyama S; Kishi K; Takahashi M; Shibata A
Bone Marrow Transplant; 1991 Oct; 8(4):301-5. PubMed ID: 1756327
[TBL] [Abstract][Full Text] [Related]
2. Comparative heat sensitivity of murine and human hemopoietic progenitors and clonogenic leukemia cells.
Gidáli J; Fehér I; Kovács P
Stem Cells; 1994 Sep; 12(5):533-8. PubMed ID: 7804126
[TBL] [Abstract][Full Text] [Related]
3. The effect of a combined purging with mafosfamide and hyperthermia on murine haemopoietic stem cells and leukaemogenic cells.
Gidáli J; Fehér I
Bone Marrow Transplant; 1992 Dec; 10(6):479-83. PubMed ID: 1490197
[TBL] [Abstract][Full Text] [Related]
4. Effect of hyperthermia on both primary proliferation and self-renewal of human leukemic progenitor cells in vitro: its application to in vitro purging.
Moriyama Y; Nikkuni K; Saito H; Aoki A; Kishi K; Takahashi M; Shibata A
Leukemia; 1991 Apr; 5(4):332-5. PubMed ID: 2027300
[TBL] [Abstract][Full Text] [Related]
5. The effect of a prolonged in vitro exposure to 1-beta-D arabinofuranosylcytosine and deoxycytidine on the survival of normal (CFU-GM) and leukemic (L-CFU) human myeloid progenitor cells in suspension culture.
Grant S; Bhalla K; Arlin Z; Howe CW
Exp Hematol; 1990 Jan; 18(1):41-8. PubMed ID: 2298268
[TBL] [Abstract][Full Text] [Related]
6. Enhanced elimination of Ph+ chromosome cells in vitro by combined hyperthermia and other drugs (AZT, IFN-alpha, TNF, and quercetin): its application to autologous bone marrow transplantation for CML.
Osman Y; Moriyama Y; Shibata A
Exp Hematol; 1995 May; 23(5):444-52. PubMed ID: 7720816
[TBL] [Abstract][Full Text] [Related]
7. Hyperthermic purging in vitro of murine leukemia cells (MK-8057): surviving fractions of normal and leukemic stem cells and the long-term survival of mice injected with the post-hyperthermic leukemia cells.
Iwasawa T; Hirabayashi Y; Kubota N; Inoue T; Kakehi M; Matsui K
Exp Hematol; 1991 Jun; 19(5):332-7. PubMed ID: 2026185
[TBL] [Abstract][Full Text] [Related]
8. Normal and malignant human myeloid progenitors differ in their sensitivity to hyperthermia.
Murphy PB; Richman CM
Exp Hematol; 1989 Dec; 17(11):1105-9. PubMed ID: 2583254
[TBL] [Abstract][Full Text] [Related]
9. In vitro sensitivity of human hematopoietic progenitor cells to hyperthermia: critical temperature for cells to survive and its application to in vitro purging.
Moriyama Y; Nikkuni K; Saito H; Aoki A; Furukawa T; Imanari A; Narita M; Kishi K; Takahashi M; Shibata A
Bone Marrow Transplant; 1990 Oct; 6(4):243-6. PubMed ID: 2085698
[TBL] [Abstract][Full Text] [Related]
10. Killing effect of interleukin-2 and interferon-alpha activated leukemic bone marrow in remission on K562 leukemic cells.
Li C; Yan W; Hao Y; Han M; Qiu L; Liu H; Han J; Li X; Feng S
Chin Med J (Engl); 1999 Jan; 112(1):53-5. PubMed ID: 11593642
[TBL] [Abstract][Full Text] [Related]
11. Effects of recombinant human tumor necrosis factor on highly enriched hematopoietic progenitor cell populations from normal human bone marrow and peripheral blood and bone marrow from patients with chronic myeloid leukemia.
Wisniewski D; Strife A; Atzpodien J; Clarkson BD
Cancer Res; 1987 Sep; 47(18):4788-94. PubMed ID: 3040231
[TBL] [Abstract][Full Text] [Related]
12. The suppressive influences of human tumor necrosis factors on bone marrow hematopoietic progenitor cells from normal donors and patients with leukemia: synergism of tumor necrosis factor and interferon-gamma.
Broxmeyer HE; Williams DE; Lu L; Cooper S; Anderson SL; Beyer GS; Hoffman R; Rubin BY
J Immunol; 1986 Jun; 136(12):4487-95. PubMed ID: 3086433
[TBL] [Abstract][Full Text] [Related]
13. In vitro sensitivity of post-bone marrow transplantation CFU-GM and BFU-E to TNF-alpha and IFN-gamma.
Papadakis V; Ferguson KF; Heller G; Kernan NA
Exp Hematol; 1995 Dec; 23(14):1422-30. PubMed ID: 8542927
[TBL] [Abstract][Full Text] [Related]
14. The cytotoxicity of alkyl-lysophospholipid on clonogenic leukemia cells and on normal bone marrow progenitor cells is highly, but differentially, increased by cryopreservation.
Verdonck LF; Heesbeen EC; van Heugten HG; Staal GE; Rijksen G
Bone Marrow Transplant; 1992 Apr; 9(4):241-5. PubMed ID: 1600412
[TBL] [Abstract][Full Text] [Related]
15. In vitro purging of clonogenic leukemic cells from human bone marrow by heat: simulation experiments for autologous bone marrow transplantation.
Moriyama Y; Hashimoto S; Goto T; Furukawa T; Kishi K; Takahashi M; Shibata A
Leuk Res; 1992 Oct; 16(10):973-7. PubMed ID: 1405711
[TBL] [Abstract][Full Text] [Related]
16. The effects of acetaldophosphamide, a novel stable aldophosphamide analogue, on normal human and leukemic progenitor cells in vitro: implications for use in bone marrow purging.
Beran M; Andersson BS; Wang Y; McCredie KB; Farquhar D
Cancer Res; 1988 Jan; 48(2):339-45. PubMed ID: 3275495
[TBL] [Abstract][Full Text] [Related]
17. [The killing effect of IL-2 and IFN-alpha activated bone marrow on K562 leukemic cell].
Li C; Yan W; Hao Y; Feng S; Qiu L; Liu H; Han J; Li X; Feng S
Zhonghua Xue Ye Xue Za Zhi; 1997 Aug; 18(8):410-2. PubMed ID: 15625846
[TBL] [Abstract][Full Text] [Related]
18. Enhanced selectivity of hyperthermic purging of human progenitor cells using Goralatide, an inhibitor of cell cycle progression.
Wierenga PK; Brenner MK; Konings AW
Bone Marrow Transplant; 1998 Jan; 21(1):73-8. PubMed ID: 9486498
[TBL] [Abstract][Full Text] [Related]
19. Clonogenic leukemic progenitor cells in acute myelocytic leukemia are highly sensitive to cryopreservation: possible purging effect for autologous bone marrow transplantation.
Allieri MA; Lopez M; Douáy L; Mary JY; NGuyen L; Gorin NC
Bone Marrow Transplant; 1991 Feb; 7(2):101-5. PubMed ID: 2049553
[TBL] [Abstract][Full Text] [Related]
20. Interferon protects normal human granulocyte/macrophage colony-forming cells from Ara-C cytotoxicity.
Richman CM; Slapak CA; Toh B
J Biol Response Mod; 1990 Dec; 9(6):570-5. PubMed ID: 1705960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
